Press Releases

Viscira™ Earns Industry Praise for Next-Generation 3D Animation Production

3D animation has progressed significantly - from the hand-drawn techniques used in the 1940 production of Pinocchio to the groundbreaking technologies used to create the 2009 science fiction epic film, Avatar. While many are familiar with the use of animation by the motion picture industry, most are not as aware of its potential within the medical environment.

Viscira, a leading provider of interactive and new-media solutions for the life sciences industry, is capitalizing on this opportunity by offering deep and broad experience in 3D disease state and mechanism of action (MOA) animation development. Viscira is raising the bar for animation productions having recently received industry praise for an animation video it featured at the 2009 American Society of Clinical Oncology (ASCO) Meeting.

Brad Peebler, CEO of Luxology, the software developer for the featured animation, commented on Viscira’s delivery at ASCO. “We are impressed with the quality and sophistication of animation that Viscira is able to deliver. It’s great to see some of the unique effects that are typically reserved for feature-film production incorporated into a medical video.”

While Viscira’s cinematic animations engage and entertain viewers, they also educate through a medically-sophisticated, storytelling approach that strives for scientific accuracy even at a cellular or molecular level. When appropriate, Viscira’s animations can provide viewers with a photo-realistic visual experience that might resemble the perspective of looking through a microscope.

According to Hagop (Kane) Kaneboughazian, Viscira’s Director of Animation, success depends on blending creative design with science. “We start with primary research on a disease state and product, key message definition and script development. It’s critical to understand the science first to make sure that the visual components are not only aesthetically impactful, but also technically correct.”

Viscira produces stunning 3D animations that can be customized for healthcare professionals, as well as patients. The company’s animation team brings together multiple functions including medical writers, storyboard artists and motion graphics developers. Viscira’s technical animation development suite integrates some of the same software programs and tools being utilized by companies such as Pixar and Lucasfilm, in addition to in-house applications.

Viscira’s next-generation 3D animations are just one of many interactive and new-media solutions the company offers, which range from web-based interactive slide kit builder platforms to enhanced video presentation modules to virtual-reality tradeshow programs. Viscira’s strategic approach combined with its delivery of cutting-edge products has resulted in an impressive roster of clients for the company including Amgen, Johnson & Johnson, Genentech, Pfizer and Novartis.

Press Contact:
Noël Ashekian
Marketing Communications Manager - Viscira
Phone: (617) 429-0834
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Click Here to read this article on PRWeb

Viscira Expands Interactive Solutions to Reduce Marketing Expenses for Pharmaceutical Companies in Challenging Economic Times

The current poor economic conditions have driven many companies to take cost cutting measures to maintain profitability. Marketing is certainly one area of focus as companies look for more affordable and efficient ways to reach their customers.

During these turbulent economic times, pharmaceutical companies are also looking to gain efficiencies by seeking lower cost and more streamlined distribution channels to reach health care professionals and patients, especially as the sales force numbers continue to shrink. According to a March 2009 report published by consulting firm ZS Associates, the number of pharmaceutical reps decreased from 102,000 in 2007 to 92,000 in the first quarter of 2009. This number is expected to dip to as low as 75,000 by 2012.*

Viscira (, a San Francisco based interactive and new-media company delivering innovative technology solutions to the life sciences industry, is responding to these challenges by leveraging electronic channels such as the web, email and mobile devices in new and compelling ways to enable life science clients to directly reach their target audiences.

Viscira provides a variety of innovative and differentiated interactive solutions ranging from next-generation 3D product animations and interactive medical case studies to web-based speaker training platforms and electronic journal reprints to deliver dynamic content to an industry that understands the importance of innovation. The company continues to expand its product offerings to respond to the growing demands of customers.

“Many of our technology solutions can be delivered directly to end users and can also be cost-effectively repurposed for multiple distribution channels to help maximize client investment.” explains Dave Gulezian, President and CEO of Viscira. “Moreover, we offer a number of unique products that can help make the pharma sales force more effective even if their overall numbers might be smaller.”

Further facilitating this shift is the growing acceptance and adoption of new technology and electronic communication by patients and healthcare professionals. In fact, the number of physicians who use the Internet and other technology to access pharmaceutical, biotech, and medical device information has grown to almost 90% of the total U.S. physician population.**

“The Internet and other new media channels are becoming increasingly important ways for myself and my colleagues to stay current on new developments in patient care,” says Dr. Anthony Padula, a leading rheumatologist practicing in the San Francisco Bay area. “However, the quality of the educational programs delivered through these channels must be very high if they are to be effective.”

Beyond providing innovative interactive products, Viscira takes a strategic approach when working with its clients by investing in fully understanding their marketing goals and objectives. This methodology allows the company to leverage its technology expertise, marketing savvy and scientific knowledge to obtain outstanding results.

Viscira’s strategic approach combined with its delivery of cutting-edge products has resulted in an impressive roster of clients for the company including Amgen, Johnson & Johnson, Genentech, Pfizer and Novartis. The company also boasts a medical advisory board comprised of leading healthcare practitioners from some of the country’s leading medical institutions.

*Drivers of Change to Pharmaceutical Commercial Models, ZS Associates, March 2009.

**Plugging into Physicians: Digital Marketing & Sales Strategies for Healthcare Companies, Manhattan Research, 2008.

Press Contact:
Noël Ashekian
Marketing Communications Manager - Viscira
Phone: (617) 429-0834
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Click Here to read this article on PRWeb

Growing iPad Usage by Physicians Provides Additional Opportunity for Viscira®


Since the launch of the iPad in 2010, Apple has sold ~58 million units worldwide.(1) The company currently maintains an estimated 70% market share in the tablet market affirming its dominant position in the space. (2)

According to Manhattan Research, physicians have been one of the biggest adopters of this mobile device. Their most recent survey of US physicians in 25 specialties found that 45% currently owned an iPad, with an additional 29% stating that they planned to purchase this product within the next six months (as of May 2012) (3).

Physicians report using their mobile devices for various professional purposes including communicating with colleagues, accessing treatment guidelines, referencing drug information, reading journal articles and abstracts, checking formulary status, etc.

Viscira, a leading provider of interactive, new-media and technology solutions for the life sciences industry, has experienced significant growth aided by the wave of iPad adoption by medical groups and physicians of all kinds. The company continues to see a significant increase in business coming from their development of innovative iPad apps for their clients, many of which are ultimately used or seen by physicians.

The company is fully leveraging its industry knowledge, creative design skills, video and animation production capabilities and software programming expertise to develop a wide array of unique, visually-stunning applications for the iPad and other mobile devices including:

  • Dynamic interactive sales aids for disease and product education
  • Interactive treatment algorithms and product dosing calculators
  • Interactive presentation builder and delivery platforms
  • User-friendly disease management and medication adherence tools

In addition, the company can optimize nearly all of its web-based solutions for iPad viewing, including 3D MOA animations, enhanced KOL videos, product and disease education websites, and interactive case studies.

“Viscira is uniquely positioned to continue capitalizing on the growing trend of iPad usage by physicians and our life science clients,” explains Dave Gulezian, President & CEO of Viscira. “Our ability to seamlessly integrate multiple media types and interactive elements, using the diverse array of skill sets within the company, enables us to deliver engaging apps that truly leverage the device hardware and have lasting impact.”

1. CNET News, March 11, 2012

2. TechCrunch, April 24, 2012

3. Manhattan Research, “Taking the Pulse US v12.0”, 2012

Click here to read the full article

Viscira® Continues Strong Business Performance in Q1 2012

Viscira, a leading provider of interactive, new-media and technology solutions for the life sciences industry, continued its stellar business performance into the first quarter of 2012. The company realized an 80 percent increase in revenue for Q1 2012 versus the same period in 2011. This accelerated growth follows on the heels of an increase of more than 65 percent in annual gross revenue for FY 2011 over the prior fiscal year based on the company’s final accounting results.

During the first quarter, Viscira added several new clients, including Otsuka Pharmaceuticals and Teva Pharmaceuticals, to its already impressive client list of life sciences customers. The company also increased its volume of business with existing clients such as Genentech, Roche, Johnson & Johnson, Bristol-Myers Squibb and Novartis.

To satisfy this growing demand, the company continues to aggressively recruit talented professionals across multiple functional areas. Viscira is also exploring options to expand its office infrastructure both at its headquarters location in San Francisco and in New York.

“We are very pleased that we have been able to carry our business momentum forward from last year into 2012,” explains Dave Gulezian, President & CEO of Viscira. “We are passionate about the innovative technology solutions we are delivering, and will work to sustain these strong operating results throughout the year.”

Viscira’s growth has been driven by increasing demand across the company’s portfolio of interactive products and software platforms from next-generation, 3D mechanism of action animations to enhanced KOL video presentation modules to its robust online Interactive Presentation Builder (IPB) solution. Viscira also expects demand for the company’s distinctive iPad applications for the industry to continue to grow significantly through the remainder of 2012 and into the foreseeable future.

Click Here to read the full article

News by Year Press Releases - News page